NUP98 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.93539999998804E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.51480000005245E-07 |
Normal-vs-Stage2 |
8.723300E-03 |
Normal-vs-Stage3 |
6.261000E-01 |
Normal-vs-Stage4 |
2.218300E-02 |
Stage1-vs-Stage2 |
2.296400E-01 |
Stage1-vs-Stage3 |
1.572130E-04 |
Stage1-vs-Stage4 |
3.560800E-01 |
Stage2-vs-Stage3 |
1.035830E-01 |
Stage2-vs-Stage4 |
9.882800E-01 |
Stage3-vs-Stage4 |
1.937580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.37839999994716E-06 |
Normal-vs-AfricanAmerican |
3.606100E-04 |
Normal-vs-Asian |
5.591000E-01 |
Caucasian-vs-AfricanAmerican |
7.050800E-01 |
Caucasian-vs-Asian |
1.890760E-01 |
AfricanAmerican-vs-Asian |
2.097800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.26039999840344E-08 |
Normal-vs-Female |
1.054220E-01 |
Male-vs-Female |
6.572300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
5.772500E-04 |
Normal-vs-Extreme_Weight |
2.38970000010497E-07 |
Normal-vs-Obese |
5.981200E-03 |
Normal-vs-Extreme_Obese |
3.66099999999925E-05 |
Normal_Weight-vs-Extreme_Weight |
2.806800E-01 |
Normal_Weight-vs-Obese |
4.162400E-01 |
Normal_Weight-vs-Extreme_Obese |
1.933240E-01 |
Extreme_Weight-vs-Obese |
4.776200E-02 |
Extreme_Weight-vs-Extreme_Obese |
3.878800E-01 |
Obese-vs-Extreme_Obese |
2.308300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.224000E-01 |
Normal-vs-Age(41-60Yrs) |
2.236300E-04 |
Normal-vs-Age(61-80Yrs) |
5.56689999986482E-07 |
Normal-vs-Age(81-100Yrs) |
4.3439000000034E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.844170E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.036700E-03 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.924700E-03 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.485600E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.361600E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.888200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.04980000248389E-08 |
Normal-VS-Type2 PRCC |
2.577600E-04 |
Normal-VS-KIRP CIMP |
4.522100E-02 |
Normal-VS-Unclassified PRCC |
1.594350E-02 |
Type1 PRCC-VS-Type2 PRCC |
1.307580E-01 |
Type1 PRCC-VS-KIRP CIMP |
2.515600E-03 |
Type1 PRCC-VS-Unclassified PRCC |
1.506500E-02 |
Type2 PRCC-VS-KIRP CIMP |
4.836100E-03 |
Type2 PRCC-VS-Unclassified PRCC |
3.163000E-01 |
KIRP CIMP-VS-Unclassified PRCC |
8.898000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.96530000554185E-08 |
Normal-vs-N1 |
4.840800E-01 |
Normal-vs-N2 |
2.179200E-01 |
N0-vs-N1 |
6.761700E-04 |
N0-vs-N2 |
2.565400E-01 |
N1-vs-N2 |
3.419400E-01 |
|
|